companiesCompany
Section 32 (S32)
Section 32 is a venture firm founded by the former head of Google Ventures that invests across biology, healthcare and computing, including AI-native cancer diagnostics and therapeutics companies.
Overview
Section 32, now branded S32, is a venture capital firm founded in 2017 by Bill Maris after he left GV. It invests at the intersection of technology and life sciences, from early rounds to growth, with oncology exposure through diagnostics, AI-driven drug discovery and therapeutics. Portfolio links in OnCo are derived from the startup records that name it.
Portfolio in OnCo (3)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Exai Bio Palo Alto, CA, US | Startup | diagnostics | Series A 2021, $68M | |
| Nested Therapeutics Cambridge, MA, US | Startup | biotech | Series A 2022, $90M | |
| Nucleai Tel Aviv, IL | Startup | ai software | none on record |
Pages like this
not linked directly; found by shared links- CompanyCasdin Capital
Shares Exai Bio and the tag vc.
- CompanyVersant Ventures
Shares Nested Therapeutics and the tag vc.
- CompanyForesite Capital
Shares Nested Therapeutics and the tag vc.